{
    "Question": "Sequenex CES 2024 product highlight and specification",
    "Summary": "Sequenex\n\nCES 2024\n\n- Specialized in diabetes, medtech, and connected devices software\n- Agile mindset and ISO 13485 Certified QMS for efficient and compliant software development\n- Focus on continuous delivery, compliance, automated testing, and documentation\n- Expertise in developing clinical apps, commercial apps, proof of concept apps, and SDKs for digital health and medtech companies\n- Cloud solutions with identity-enabled microservice architectures\n- Interoperable digital health solutions for managing diabetes and chronic conditions\n- Identity Management specialists offering advice on choosing the right provider",
    "Summary_cn": "Sequenex\n\nCES 2024\n\n- 专注于糖尿病、医疗技术和连接设备软件\n- 敏捷思维和 ISO 13485 认证的 QMS，以实现高效合规的软件开发\n- 专注于持续交付、合规性、自动化测试和文档编制\n- 在开发数字健康和医疗技术公司的临床应用、商业应用、概念验证应用程序和 SDK 方面具备专业知识\n- 基于云的解决方案，采用身份管理微服务架构\n- 用于管理糖尿病和慢性病的互操作数字健康解决方案\n- 身份管理专家，提供选择合适供应商的建议"
}